Apollo Hospitals Enterprise, a Rs.4,600 crore entity, has posted net profit growth of 9.8 per cent during the first quarter ended June 2015 to Rs.90.84 crore as against Rs.82.74 crore in the corresponding period of last year. Interest burden put pressure on bottom line as its interest cost went up by 42 per cent to Rs.26.86 crore from Rs.18.92 crore. EBDITA moved up by 13.8 per cent to Rs.185.24 crore from Rs.162.74 crore. Its income from operations improved by 20 per cent to Rs.1,265 crore from Rs.1,054 crore. EPS worked out to Rs.6.53 as against Rs.5.95 in the last period.

Its revenues from healthcare services increased by 11.6 per cent to Rs.745.02 crore from Rs.667.59 crore in the similar quarter of last year and that from pharmacy moved up sharply by 34.7 per cent to Rs.520.05 crore from Rs.386.22 crore.

For the full year ended March 2015, Apollo's net sales amounted to Rs.4,593 crore and it earned a net profit of Rs.347 crore with EPS of Rs.24.91. After the announcement of financial performance, Apollo scrip declined by Rs.17.40 to Rs.1426 on BSE from previous day's close of Rs.1443.40. Apollo has conducted over 1,500 solid organ transplants in 2014-15 and treated 65,000 cardiac patients including more than 12,000 PTCAs and 7,000 CABGs, 36,000 cancer patients, 25,000 patients with orthopedic problems and 27,000 needing neuro attention.